Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesTesticular cancer: RPLND an effective first-line alternative to chemotherapy
NCP Urology, 06/11/09
Payton S - Men with nonseminomatous germ cell tumors (NSGCTs) who are at high risk of metastasis can benefit from retroperitoneal lymph node dissection (RPLND) as primary treatment. The recent development of safer dissection techniques that reduce the risk of retrograde ejaculation add to its potential as a first-line treatment in testicular cancer. Long-term complications linked to cisplatin-based treatment include cardiovascular disease and metabolic syndrome. Secondary malignancy associated with radiation exposure during post-chemotherapy follow-up CT imaging would also be avoided by employing this management strategy.
Related Articles
Testicular cancer: addressing the psychosexual issues
British Journal of Nursing, 10/27/09
Relevance Score: 70%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 69%
New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09
Relevance Score: 69%
Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09
Relevance Score: 68%
The predictive value of testicular ultrasound abnormalities for carcinoma in situ of the testis in men at risk for testicular cancer
International Journal of Andrology, 10/23/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital
Urologia Internationalis, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Today in Testis/Scrotum...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Initial experiences of a testicular sperm extraction programme for assisted reproduction in Ireland
Irish Journal of Medical Science, 12/18/09
A 2-year-old boy with a stage III yolk sac tumor occurring in an intra-abdominal retained testis
Journal of Pediatric Surgery, 12/18/09
Article Search
Sponsor